Su Min Wu
Corporate Officer/Principal bei Nanjing Chang'ao Pharmaceutical Co., Ltd.
Profil
Su Min Wu is currently the General Manager at Nanjing Chang'ao Pharmaceutical Co., Ltd.
Prior to this, from 2005 to 2010, Wu worked as an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
Aktive Positionen von Su Min Wu
| Unternehmen | Position | Beginn |
|---|---|---|
| Nanjing Chang'ao Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 23.04.2010 |
Ehemalige bekannte Positionen von Su Min Wu
| Unternehmen | Position | Ende |
|---|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 09.12.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
| Nanjing Chang'ao Pharmaceutical Co., Ltd. |
